The global Heart Pump Device market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Heart Pump Device volume and value at global level, regional level and company level. From a global perspective, this report represents overall Heart Pump Device market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Heart Pump Device in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Heart Pump Device manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
St. Jude Medical (subsidiary of Abbott Laboratories) (US)
Abiomed (US)
Medtronic (Ireland)
Getinge (Sweden)
Teleflex (US)
ReliantHeart (US)
BerlinHeart (Germany)
Terumo (Japan)
SynCardia Systems (US)
TandemLife (CardiacAssist) (US)
Jarvik Heart (US)
Fresenius Medical Care (Germany)

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Ventricular Assist Devices (VADs)
Intra-aortic Balloon Pumps (IABPs)
Total Artificial Heart (TAH)

Segment by Application
Bridge-to-transplant (BTT)
Bridge-to-candidacy (BTC)
Destination Therapy (DT)
Others